Rybelsus in the US, now the Ozempic pill

What is sold here

In the US the oral semaglutide tablet for type 2 diabetes is now sold as Ozempic tablets, usually called the Ozempic pill. The FDA approved the Ozempic name for the newer 1.5 mg, 4 mg and 9 mg tablets on 30 January 2026 (Novo Nordisk announced it on 4 February 2026) and they launched on 4 May 2026. They replace the Rybelsus 3 mg, 7 mg and 14 mg tablets: 1.5 mg is equivalent to 3 mg, 4 mg to 7 mg and 9 mg to 14 mg, thanks to a reformulation that is absorbed better. Novo Nordisk stopped shipping Rybelsus to wholesalers in May 2026 and remaining stock became limited from July 2026, so the Rybelsus brand has been retired in the US. Insurer notices (Illinois Medicaid, Priority Health) say people switching need a new prescription for Ozempic tablets; patients are not converted automatically. A 25 mg Ozempic tablet has been filed with the FDA, with a decision expected by the end of 2026.

What it is licensed for

Type 2 diabetes in adults, alongside diet and exercise, to improve blood sugar control, and to reduce the risk of major cardiovascular events (heart attack, stroke or cardiovascular death) in adults with type 2 diabetes at high cardiovascular risk. It is not approved for weight loss; the Wegovy pill is the oral semaglutide approved for weight management.

Prescription rules

Prescription-only (Rx). A prescription can come from your own doctor or from a licensed telehealth clinician after an online consultation.

How to get a prescription

If you have type 2 diabetes, the usual route is your own doctor or endocrinologist, who can prescribe the Ozempic pill and send it to a local pharmacy, a mail-order pharmacy or NovoCare Pharmacy. If you have commercial insurance, ask the pharmacy to apply Novo Nordisk's savings card; if you are on Medicare Part D or Medicaid, coverage depends on your plan's formulary and usually needs prior authorization.

If you do not have a regular doctor, licensed telehealth services can prescribe after an online consultation. You fill in a medical questionnaire, may need recent lab results such as an HbA1c, and a clinician licensed in your state reviews it, sometimes with a video visit. Telehealth fees vary: some charge a one-off visit fee, others a monthly membership, and the medicine is usually charged separately at or near the manufacturer's self-pay price.

If you are paying cash, the manufacturer's self-pay prices ($149, $199 or $299 a month depending on strength) apply at NovoCare Pharmacy and at local pharmacies with Novo's offer, so it is worth comparing the total monthly cost (medicine plus any membership) before choosing a service. If you already take Rybelsus, ask your prescriber for a new prescription for the equivalent Ozempic pill strength.

Cost and cover

Medicare Part D, Medicaid and private insurance

There is no national health service. Most commercial insurance plans and most Medicare Part D plans cover semaglutide for type 2 diabetes, usually with prior authorization, and the Ozempic pill has the same prescribing information as Rybelsus, so plans have generally moved Rybelsus coverage across. Some insurers converted existing Rybelsus prior authorizations automatically; others require a new request.

State Medicaid programs cover GLP-1 medicines for type 2 diabetes, typically with prior authorization and a small or no co-pay; for example Illinois Medicaid lists both Rybelsus and Ozempic tablets as preferred with prior authorization.

People with commercial insurance may be able to use Novo Nordisk's savings card to pay as little as $25 a month for up to 3 months (maximum saving $100 a month); people on Medicare, Medicaid or other government plans cannot use it. The Medicare GLP-1 Bridge ($50 a month, 1 July 2026 to 31 December 2027) covers Wegovy, Foundayo and Zepbound for weight loss only and excludes people with type 2 diabetes, who continue to get the Ozempic pill through their normal Part D plan.

Paying yourself

Paying cash, the Ozempic pill costs $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg (30 tablets) through NovoCare Pharmacy, which is Novo Nordisk's own home-delivery pharmacy, and the same self-pay prices are available at local pharmacies with Novo's savings offer, Costco Pharmacy (for members), Amazon Pharmacy and through GoodRx. Telehealth services add their own consultation or membership fees on top, typically from about $29 a visit to $149 a month. With commercial insurance, the savings card can bring the co-pay down to $25 a month for up to 3 months.

Before the rename, Rybelsus had a list price of about $998 for 30 tablets and pharmacy cash prices of roughly $1,000 to $1,400 a month; we found no published manufacturer self-pay price for Rybelsus, so most people used it with insurance. Novo Nordisk has announced that the list price of its semaglutide medicines (including Rybelsus 7 mg and 14 mg) will fall to $675 a month from 1 January 2027; this does not change the self-pay prices.

Prices checked 22 September 2026. They change; the supplier's own site is the final word.

Checking a pharmacy is genuine

Pharmacies are licensed state by state, and an online pharmacy must be licensed in the state it ships to. To check one: find the dispensing pharmacy's name on the site (telehealth services usually name their partner pharmacy), then look it up on the licence search of your state board of pharmacy, which you can find through NABP's board directory or the FDA's BeSafeRx page.

Two voluntary checks add confidence. NABP's Digital Pharmacy Accreditation is only open to licensed US pharmacies and requires a .pharmacy web address, so a site ending in .pharmacy has passed NABP's review; NABP also lists accredited sites and sites it does not recommend at safe.pharmacy. LegitScript certifies online pharmacies and telehealth services (Google, Meta and the card networks rely on it), and you can enter a web address in its certification lookup to see whether the site is certified.

Warning signs of a rogue site: no prescription required, prices far below the manufacturer's self-pay price, no US address or pharmacist contact, or shipping from outside the US.

• Medicines regulatorUS Food and Drug Administration (FDA) ↗
• Pharmacy regulatorState boards of pharmacy, with the National Association of Boards of Pharmacy (NABP) and LegitScript ↗
• Prescriber regulatorState medical boards (doctors, including telehealth clinicians, must be licensed in the patient's state); licence lookup via the Federation of State Medical Boards' DocInfo.org ↗

Fake semaglutide is widespread. Any site that offers Rybelsus without a prescription, or at a price far below everyone else, should be avoided. How to buy safely.

Other options in the US

How the other semaglutide and GLP-1 medicines stand here. Tablets first; injections for comparison.

• Wegovy pill Tablet · semaglutide (oral) Available

  Oral semaglutide for weight management (1.5 mg, 4 mg, 9 mg, 25 mg), FDA-approved on 22 December 2025 and launched in early January 2026. Self-pay $149 (1.5 mg), $199 (4 mg; $149 until 31 August 2026), $299 (9 mg and 25 mg) a month. Covered by the Medicare GLP-1 Bridge for eligible people from 1 July 2026.

• Foundayo Tablet · orforglipron Available

  Eli Lilly's orforglipron, a once-daily non-peptide GLP-1 pill for weight management that can be taken at any time of day without food or water restrictions. FDA-approved on 1 April 2026; shipping from LillyDirect began on 6 April 2026, followed by retail pharmacies and telehealth. LillyDirect self-pay prices run from $149 a month (0.8 mg) to $349 a month for the top strengths ($299 if refilled within 45 days), with temporary reductions on 2.5 mg and 5.5 mg through 31 December 2026. Covered by the Medicare GLP-1 Bridge for eligible people.

• Ozempic Injection · semaglutide (injection) Available

  Once-weekly semaglutide injection for type 2 diabetes, FDA-approved in December 2017. NovoCare Pharmacy self-pay: $199 a month for the first two months of 0.25 mg or 0.5 mg for new patients (offer through 31 December 2026), then $349 a month for 0.25 mg, 0.5 mg or 1 mg and $499 a month for 2 mg.

• Wegovy Injection · semaglutide (injection) Available

  Once-weekly semaglutide injection for weight management, FDA-approved in June 2021. NovoCare Pharmacy self-pay: $199 a month for the first two months of 0.25 mg or 0.5 mg for new patients (through 31 December 2026), then $349 a month, or $399 a month for the Wegovy HD 7.2 mg pen.

• Mounjaro Injection · tirzepatide Available

  Once-weekly tirzepatide injection for type 2 diabetes, FDA-approved in May 2022. The same medicine is sold for weight management as Zepbound.

• Generic semaglutide Injection · semaglutide Not approved

  No generic semaglutide is marketed in the US; semaglutide is not expected to lose US patent protection before December 2031. Compounded semaglutide is not FDA-approved: the FDA declared the semaglutide shortage over on 21 February 2025 and the grace periods for mass compounding ended on 22 April 2025 (503A pharmacies) and 22 May 2025 (503B outsourcing facilities). Compounded products are outside the scope of this site.